Eurofins-Cerep SA
EPA:ALECR.PA
19,100 (EUR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Eurofins-Cerep SA |
Symbool | ALECR.PA |
Munteenheid | EUR |
Prijs | 19,100 |
Beurswaarde | 96,340,400 |
Dividendpercentage | 0% |
52-weken bereik | 18,400 - 26,200 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Antoine Duthilleul |
Website | https://www.eurofins.fr/cerep |
An error occurred while fetching data.
Over Eurofins-Cerep SA
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)